Author Archive: Jason Corum

Jason Corum

Jason is the director of web and new media with the Biotechnology Industry Organization (BIO). Prior to joining BIO in March 2011, he was the online communications manager for World Food Program USA and an online communications specialist with the Brookings Institution.

Jason is originally from Evergreen Park, Ill. and still thinks that Chicago is the best food city in the nation.  He spends his free time volunteering with the DC Books to Prisons Project, watching movies and reading comics.

Latest Posts

Reverse Mergers: A Company is Ready to Go Public, or it’s Not

The latest IPO window has stalled. There have been five IPO withdrawals since June and around 30 since 2005. Global macro events are threatening to completely shut it. Reverse mergers have become an increasingly popular option with eight transactions in the last year. Unfortunately, 47 percent of reverse mergers have decreased in value post-close since 2008. At the 2011 BIO Investor Forum, a panel of experts examined the current financing environment and what private executive Read More >

Business of Biotech  |  2 Comments  |  Email This Post
Tags: , , , ,

Increasing Partnering at BIO

Partnering Meetings

Mike May from Biotech Tallies writes: At the 2011 BIO International Convention, the number of one-on-one partnering meetings soared to 21,183… The increasing number of such meetings probably reflects the growth in biotechnology, the escalating importance of BIO’s annual meeting and the expanding need to partner for success in this field.

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,

Stopping ALS: An interview with Dr. Perrin from ALS TDI

thumb

What is ALS? How widespread is the disease? Are there any treatments for ALS? Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease and outside the US as Motor Neuron Disease (MND) or Charcot’s Disease, is a progressive neurodegenerative disease that attacks motor neurons in the brain (upper motor neurons) and spinal cord (lower motor neurons) and affects muscle function. Dr. Steven Perrin is the CEO, CSO and Vice Chairman of the ALS Therapy Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , ,

Could 3 minutes reshape California’s biotech future?

Ron Leuty from BiotechSF writes: In just three minutes the other day, Maryland received more than 180 applications for its $8 million biotech tax credit program. The program, which rewards investors for putting cash in biotech startups, is one of many that states are offering to jumpstart or grow their life sciences communities.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

They engineered a better salmon, so why is Congress blocking it?

Steven Salzberg from Fighting Pseudoscience writes: What happened to genetically modified salmon? A few months back I was looking forward to my first taste of the new AquaBounty salmon, which grows to maturity twice as fast as wild salmon. Will it taste just as good? Better? I thought I’d know soon. But then politics intervened. Fighting Pseudoscience is a blog from Forbes.

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,